Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.690
+0.100 (6.29%)
At close: Apr 23, 2026, 4:00 PM EDT
1.700
+0.010 (0.59%)
Pre-market: Apr 24, 2026, 7:01 AM EDT

Neuronetics Revenue

In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth. Neuronetics had revenue of $41.78M in the quarter ending December 31, 2025, with 85.73% growth.

Revenue (ttm)
$149.16M
Revenue Growth
+99.17%
P/S Ratio
0.79
Revenue / Employee
$226,682
Employees
658
Market Cap
117.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025149.16M74.27M99.17%
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 201962.66M9.88M18.72%
Dec 31, 201852.78M12.34M30.53%
Dec 31, 201740.43M6.21M18.13%
Dec 31, 201634.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Treace Medical Concepts212.69M
Quanterix138.90M
Outset Medical119.48M
Owlet105.71M
AVITA Medical71.61M
Rapid Micro Biosystems33.59M
MaxCyte33.03M
QT Imaging Holdings18.93M
Revenue Rankings